Energy dissipation via UCP1 of BAT potentially enhances the total energy expenditure of the whole body up to 20% [4]; therefore, UCP1 activation is considered a potentially promising therapeutic approach for obesity and diabetes treatment [5]. Here, UCP1 is linked to diabetes mellitus.